Effects of ultra-long acting bronchodilator therapy assessed by impulse oscillometry in smoking asthmatics taking inhaled corticosteroids - MAN05 Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics

Tayside Medical Sciences Centre on behalf of University of Dundee & NHS Tayside0 个研究点目标入组 16 人开始时间: 2015年8月11日最近更新: 2020年7月27日

适应症

试验速览

暂无简介。

•Male or female volunteers aged 18-65 years with persistent asthma and on inhaled corticosteroids (at least 400 micrograms BDP or the equivalent daily)
•Current smoker
•FEV1 > 60 % predicted
•Ability to give informed consent
•Agreement for their GP to be made aware of study participation and to receive feedback as relevant to the participant’s well being
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 16
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•Other respiratory diseases such as COPD, bronchiectasis or ABPA
•An asthma exacerbation or respiratory tract infection requiring systemic steroids and/or antibiotics within 1 month of the study commencement or 3 months if hospital admission was required
•Any clinically significant medical condition that may endanger the health or safety of the participant
•Participation in another trial within 30 days before the commencement of the study
•Pregnancy or lactation
•Unable to comply with the procedures of the protocol
•Unable or unwilling to consent

发起方

Tayside Medical Sciences Centre on behalf of University of Dundee & NHS Tayside